Maria Eleftheriadou
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The rapid access eye clinic's playbook: how to cut eye casualty attendance by 50.
Journal: Eye (London, England)
Published: January 02, 2023
Four-year outcomes of aflibercept treatment for neovascular age-related macular degeneration: Results from real-life setting.
Journal: European journal of ophthalmology
Published: June 27, 2020
Cataract service redesign in the post-COVID-19 era.
Journal: The British journal of ophthalmology
Published: May 13, 2020
Individualizing Therapy for Neovascular Age-Related Macular Degeneration with Aflibercept (VITAL): A Two-Year Prospective, Interventional Single-Centre Trial.
Journal: Ophthalmology and therapy
Published: May 07, 2020
Real-Life Evidence for Using a Treat-and-Extend Injection Regime for Patients with Central Retinal Vein Occlusion.
Journal: Ophthalmology and therapy
Published: March 01, 2019
Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting.
Journal: Ophthalmology and therapy
Published: June 04, 2018
Long-Term Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration in a Clinical Setting.
Journal: American journal of ophthalmology
Published: June 23, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026